Nearmap has had plenty of growth in 5 or 6 years - Share price doesn't always reflect company value. Early share price appeared unnaturally high, and had a correction. Given the continual ACV growth and near-term advancements (Hypercamera 3 = cheaper geographical expansion) i have no issue holding this stock until all the reinvestment pays off - may not be the investment strategy for all.
Ann: FY22 Annual Contract Value guidance, page-39
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)